In vivo T-cell depletion with antithymocyte globulins improves overall survival after myeloablative allogeneic stem cell transplantation in patients with hematologic disorders.

Zhixin Sheng,Huanwen Ma,Wenzheng Pang,Shanona Niu,Jingbo Xu

In vivo T-cell depletion with antithymocyte globulins improves overall survival after myeloablative allogeneic stem cell transplantation in patients with hematologic disorders.

2013

Zhixin Sheng
Huanwen Ma
Wenzheng Pang
Shanona Niu
Jingbo Xu

To assess the effect of prophylactic treatment with antithymocyte globulin (ATG) on graft-versus-host disease (GvHD) in myeloablative transplant patients, we performed a meta-analysis of randomized an

Keywords:

Medicine
Immunology
Diabetes mellitus
Stem cell
Globulin
In vivo
Graft-versus-host disease
Thymoglobulin
Transplantation
Disease
T-cell depletion

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations